Latest news with #VantageNXT
Business Wire
10 hours ago
- Business
- Business Wire
Verasonics Announces Enhancements to the Vantage ® NXT Research Ultrasound Platform Designed to Further Improve Capabilities in Ultrasound Research and Product Development
KIRKLAND, Wash.--(BUSINESS WIRE)-- Verasonics, Inc., the leader in research ultrasound, today announced the release of new systems and features for the Vantage NXT Research Ultrasound Platform to advance ultrasound research and product development. New enhancements include Vantage NXT 32LE and 64 System configuration models and Acquisition SDK Option features. This release will be available to all Vantage NXT customers today. 'We are excited to showcase these new enhancements with configurations and features to advance research in Biomedical, Materials Science and Industrial R&D arenas.' Enhancements to Vantage NXT in the Update include: Vantage NXT 32LE and Vantage NXT 64 system models – Available in Mid- and High-Frequency ranges, these 32- and 64-channel model configurations are ideal for customers requiring low-channel data acquisition with transmit and receive data as well as Non-Destructive Evaluation (NDE) / Non-Destructive Testing (NDT) and Materials Science research. In addition, Verasonics has released two additional Universal Transducer Adapters (UTAs) for Vantage NXT – the NXT UTA 260-MUX and NXT UTA 408-GE MUX. Acquisition SDK Option – Launched in March, the Acquisition SDK now includes programming capability for the NXT UTA 256 Direct and NXT UTA 64 LEMO, as well as the Extended Transmit Option and Vantage NXT HIFU configurations. Acquisition SDK, a C-based API, allows Vantage NXT users to program their system without MATLAB ® dependencies. The Acquisition SDK, which is comprised of a C-API, example code, and documentation, offers users similar data structures and naming conventions to those of the MATLAB Programming Model to simplify the porting of existing sequences to the Acquisition SDK environment. The Acquisition SDK is an ideal complement for users who aim to develop applications intended for commercialization or for integration of their legacy or third-party software to run on the Vantage NXT Platform. These enhancements in this update expand features for Vantage NXT users and provide more options to those considering an uptrade from the Vantage Research Ultrasound System to the Vantage NXT Research Ultrasound System. Contact sales@ regarding uptrade options. 'The Vantage NXT platform continues to expand to meet the needs of academic and commercial customers across the globe,' said Jon K. Daigle, President and Chief Executive Officer at Verasonics. 'We are excited to showcase these new enhancements with configurations and features to advance research in Biomedical, Materials Science and Industrial R&D arenas.' Visit our website for more information about Vantage NXT Research Ultrasound Systems. About Verasonics, Inc. Verasonics is a privately held company founded in 2001, with headquarters in Kirkland, Washington, USA. Verasonics, the leader in research ultrasound, is focused on providing researchers and developers with the most advanced and flexible tools enabling them to develop new algorithms and products used in biomedical ultrasound, materials science, earth sciences, and the physics of acoustics and ultrasonics. Verasonics also licenses its technology to companies for use in their commercial products. Researchers in countries across North and South America, Europe, Asia and Oceania routinely use Verasonics product solutions to advance the art and science of ultrasound through their own research efforts. Learn more by visiting the Verasonics website or following us on LinkedIn and X (Formerly Twitter).
Business Wire
3 days ago
- Business
- Business Wire
Verasonics Announces Partnership With PhotoSound Technologies, Inc.
KIRKLAND, Wash.--(BUSINESS WIRE)-- Verasonics, Inc., the leader in research ultrasound, today announced a partnership with PhotoSound ® Technologies, Inc. of Houston, TX to offer customers the PhotoSound Legion™ AMP for use with Vantage ® and Vantage NXT Research Ultrasound Systems. Partnership will offer Vantage customers expanded capabilities by integrating the Legion AMP128 in applications using photoacoustic imaging, thermoacoustic imaging, and monitoring radiation therapy, among others. 'Adding a Legion AMP unit to a Vantage or Vantage NXT platform allows researchers to refine their receive capabilities, ensuring they are capturing key data,' said Jon K. Daigle, President and Chief Executive Officer at Verasonics. Share The Legion AMP128 is a 128-channel receive signal preamplifier for use with Vantage or Vantage NXT Research Ultrasound Systems, in all channel configurations. It features high input impedance and a fixed 40db gain that amplifies weak signals especially in the lower frequency band with a high Signal to Noise Ratio (SNR). This is especially useful for research and development applications where a pulsed energy source is used where the excitation source is either weak or a long pulse. 'Adding a Legion AMP unit to a Vantage or Vantage NXT platform allows researchers to refine their receive capabilities, ensuring they are capturing key data,' said Jon K. Daigle, President and Chief Executive Officer at Verasonics. 'This partnership will allow us to better serve our mutual customer base.' 'In thermo-, photo-, and optoacoustic imaging, lower frequency signals are often underrepresented because many systems don't respond to them evenly. The Legion Amp maintains a consistent high SNR response across a broad frequency range, including below 100 kHz, which helps preserve the true shape and strength of the original signal,' said Peter Brecht, CEO of PhotoSound Technologies. 'I'm excited about this new collaboration and believe it will result in interesting new discoveries.' Learn more, visit About Verasonics, Inc. Verasonics is a privately held company founded in 2001, with headquarters in Kirkland, Washington, USA. Verasonics, the leader in research ultrasound, is focused on providing researchers and developers with the most advanced and flexible tools enabling them to develop new algorithms and products used in biomedical ultrasound, materials science, earth sciences, and the physics of acoustics and ultrasonics. Verasonics also licenses its technology to companies for use in their commercial products. Researchers in countries across North and South America, Europe, Asia and Oceania routinely use Verasonics product solutions to advance the art and science of ultrasound through their own research efforts. Learn more by visiting the Verasonics website or following us on LinkedIn and X (Formerly Twitter.) About PhotoSound Technologies, Inc. PhotoSound Technologies, Inc. was founded in September 2015 in Houston, Texas USA to develop and commercialize new biomedical imaging technologies based on optics and photoacoustics. Photoacoustic tomography (PAT) is a biomedical imaging modality combining the molecular sensitivity of optical probes with the spatial resolution of ultrasound that is ideal for a multitude of applications that can be used for pre-clinical research. Using our skills to successfully translate the technology from its experimental form, we encompass the development of biomedical systems and associated software, including imaging instrumentation, complex electronic boards for data acquisition and control, transducers, sensors, and tunable lasers. Learn more by visiting the PhotoSound website or follow us on LinkedIn.
